ETFs Are Net Sellers of IQVIA (IQV) on Nov. 13
This article first appeared on GuruFocus.
Eight ETFs were selling IQVIA (IQV) shares versus 29 buying last Friday, but the sellers moved larger amounts, producing a net outflow of $14.6 million. That followed a net outflow of $2.4 million on Thursday, extending the selling streak to two days. Before that, ETF flows had been positive for three straight sessions, including $17.7 million on Wednesday and $14.8 million on Monday.
For the full record of ETF and guru buying and selling in IQV, see the IQV guru trades page.
Which ETFs sold IQV on Friday?
The largest sellers by dollar value were DFLV ($18.3 million), IVE ($0.1 million) and USPX ($0.0 million). In all, 29 ETFs added shares and 8 cut them.
DFLV drove the move, cutting its stake by 69,040 shares, a 71.3% reduction worth $18.3 million, though the position is just 0.1% of the fund. IVE trimmed 455 shares for $0.1 million, while USPX, ESGU, SPYV, PBUS, SSO and HCMT each made negligible reductions. IQVIA operates in the Healthcare sector’s Diagnostics & Research industry and carries a $43.6 billion market cap.
Have ETFs been buying or selling IQV lately?
Over the last 5 reported days, ETFs were net buyers on 3 and net sellers on 2, so the recent trend is mostly buying.
What does IQV do?
IQVIA Holdings Inc. is a global provider of clinical research services, healthcare data, and analytics to the life sciences industry. Formed in 2016 through the merger of Quintiles and IMS Health, it operates through two segments.
IQVIA reported $17.32 billion in trailing-12-month revenue, up 13.2% year over year, with gross and net margins of 26.1% and 7.5%. It trades at a P/E of 32.17, P/B of 6.55 and P/S of 2.58. The GF Score is 93, and the GF Value of $254.78 compares with a price of $264.73. The stock is up 17.44% year to date.
IQV at a glance
Investors following IQV can review its GF Value, guru trades and insider activity on the IQV summary page.